Robert L Parkinson Jr's Net Worth

$102 Million

Estimate Recalculated Sep 11, 2024 08:08PM EST

Who is Robert L Parkinson Jr

Robert L Parkinson Jr has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include BAXTER INTERNATIONAL INC, and ENZON PHARMACEUTICALS INC.

SEC CIK

Robert L Parkinson Jr's CIK is 0001168252

Past Insider Trading and Trends

2004 was Robert L Parkinson Jr's most active year for acquiring shares with 11 total transactions. Robert L Parkinson Jr's most active month to acquire stocks was the month of February. 2011 was Robert L Parkinson Jr's most active year for disposing of shares, totalling 10 transactions. Robert L Parkinson Jr's most active month to dispose stocks was the month of February. 2013 saw Robert L Parkinson Jr paying a total of $26,163,637.50 for 1,994,162 shares, this is the most they've acquired in one year. In 2013 Robert L Parkinson Jr cashed out on 746,351 shares for a total of $54,588,791.53, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BAXTER INTERNATIONAL INC

Chairman the Board and CEO
Updated Aug 13, 2015
Form 4
1.11%
7.60K
Aug 13, 2015
693.40K
Grant
Aug 11
Form 4
44.72%
516.18K
Jul 06, 2015
4.93M
Acquisition
Jul 01
Form 4
105.89%
592.94K
$69.21
-$606.42K
Mar 05, 2015
1.15M
Grant
Mar 03 - Mar 05
Form 4
6.33%
33.34K
Feb 18, 2015
559.95K
Grant
Feb 16
Form 4
393.38K
Mar 06, 2014
393.38K
Grant
Mar 04
Form 4
6.38%
31.36K
$68.40
-$714.78K
Jan 31, 2014
523.29K
Grant
Jan 29
Form 4
11.35%
50.00K
$34.85
$871.25K
Aug 07, 2013
490.49K
Options
ScheduledAug 05
Form 4
3,500.12%
725.75K
$54.09
-$27.93M
Aug 02, 2013
490.49K
Sell-Options
ScheduledJul 31 - Aug 01
Form 4
105.86%
444.09K
Mar 07, 2013
863.61K
Grant
Mar 05
Form 4
7.14%
27.97K
$66.52
-$1.37M
Jan 18, 2013
419.52K
Grant
Jan 16
Form 4
383.51K
Mar 08, 2012
383.51K
Grant
Mar 06
Form 4
-41.32%
-275.65K
$43.53
-$4.92M
Oct 28, 2011
391.55K
Sale
ScheduledOct 27
Form 4
-32.71%
-324.35K
$43.46
-$7.61M
Oct 26, 2011
667.20K
Sale
ScheduledOct 24 - Oct 26
Form 4
330.85K
Mar 08, 2011
330.85K
Grant
Mar 04
Form 4
6.77%
21.67K
$50.30
-$605.61K
Jan 21, 2011
341.55K
Grant
Jan 19
Form 4
263.99K
Mar 05, 2010
263.99K
Grant
Mar 03
Form 4
77.44%
139.60K
$60.80
-$5.37M
Jan 22, 2010
319.88K
Grant
Jan 20
Form 4
-4.09%
-7.69K
$51.07
-$392.88K
Mar 18, 2009
180.28K
Tax
Mar 16
Form 4
254.40K
Mar 06, 2009
254.40K
Grant
Mar 04
Form 4
-8.10%
-16.56K
$56.27
-$932.06K
Mar 18, 2008
187.97K
Tax
Mar 14
Form 4
304.00K
Mar 07, 2008
304.00K
Grant
Mar 05
Form 4
166.35%
367.57K
$50.74
-$833.61K
Mar 16, 2007
588.54K
Grant
Mar 14 - Mar 15
Form 4
349.68%
596.41K
$38.35
-$310.37K
Mar 16, 2006
766.96K
Grant
Mar 14
Form 4
0.02%
34.00
Feb 21, 2006
170.56K
Options
Feb 16
Form 4
923.54%
831.19K
Mar 16, 2005
921.19K
Grant
Mar 14
Form 4
80.00%
40.00K
$34.23
$1.37M
Feb 17, 2005
90.00K
Purchase
Feb 16
Form 4
400.00%
40.00K
$32.77
$1.31M
Apr 28, 2004
50.00K
Purchase
Apr 27
Form 3
Apr 28, 2004
10.00K
Showing 28 results

ENZON PHARMACEUTICALS INC

Investor
Updated Apr 01, 2004
Form 4
Apr 01, 2004
6.74K
Options
Mar 31
Form 4
5.29K
Jan 05, 2004
5.29K
Grant
Dec 31 - Jan 02
Form 4
301.00
Oct 02, 2003
301.00
Grant
Sep 30
Form 4
Jul 02, 2003
Showing 4 results